IL56413A - Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL56413A
IL56413A IL56413A IL5641379A IL56413A IL 56413 A IL56413 A IL 56413A IL 56413 A IL56413 A IL 56413A IL 5641379 A IL5641379 A IL 5641379A IL 56413 A IL56413 A IL 56413A
Authority
IL
Israel
Prior art keywords
substituted heterocyclic
preparation
pharmaceutical compositions
compositions containing
benzamides
Prior art date
Application number
IL56413A
Other languages
English (en)
Other versions
IL56413A0 (en
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7801633A external-priority patent/FR2424909A1/fr
Application filed by Ile De France filed Critical Ile De France
Publication of IL56413A0 publication Critical patent/IL56413A0/xx
Priority to IL64928A priority Critical patent/IL64928A0/xx
Publication of IL56413A publication Critical patent/IL56413A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/28Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL56413A 1978-01-20 1979-01-11 Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them IL56413A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL64928A IL64928A0 (en) 1978-01-20 1982-02-03 Substituted benzamides and their preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7801633A FR2424909A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives d'ortho-anisamides utiles comme medicaments modificateurs du comportement, et leurs procedes de preparation
FR7831458A FR2440946A2 (fr) 1978-01-20 1978-11-07 Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement

Publications (2)

Publication Number Publication Date
IL56413A0 IL56413A0 (en) 1979-03-12
IL56413A true IL56413A (en) 1982-11-30

Family

ID=26220412

Family Applications (2)

Application Number Title Priority Date Filing Date
IL56413A IL56413A (en) 1978-01-20 1979-01-11 Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them
IL64928A IL64928A0 (en) 1978-01-20 1982-02-03 Substituted benzamides and their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL64928A IL64928A0 (en) 1978-01-20 1982-02-03 Substituted benzamides and their preparation

Country Status (39)

Country Link
US (2) US4673686A (es)
JP (1) JPS54138553A (es)
AR (2) AR221355A1 (es)
AT (2) AT377254B (es)
AU (1) AU520746B2 (es)
BE (1) BE873522A (es)
BG (2) BG48335A3 (es)
CA (1) CA1133477A (es)
CH (2) CH639369A5 (es)
CS (2) CS241016B2 (es)
CY (1) CY1202A (es)
DD (1) DD141521A5 (es)
DE (1) DE2901170A1 (es)
DK (1) DK157008C (es)
EG (1) EG13764A (es)
ES (2) ES476757A1 (es)
FI (1) FI69833C (es)
FR (1) FR2440946A2 (es)
GB (2) GB2013662B (es)
GR (1) GR64398B (es)
HK (1) HK12284A (es)
HU (1) HU177902B (es)
IE (2) IE48209B1 (es)
IL (2) IL56413A (es)
IN (1) IN150618B (es)
IT (1) IT1164821B (es)
LU (1) LU80793A1 (es)
MC (1) MC1231A1 (es)
MX (2) MX6192E (es)
NL (1) NL7900455A (es)
NO (1) NO153530C (es)
NZ (2) NZ189381A (es)
OA (1) OA06153A (es)
PL (1) PL117195B1 (es)
PT (1) PT69069A (es)
RO (2) RO76554A (es)
SE (2) SE449862B (es)
SU (1) SU1158040A3 (es)
YU (2) YU41608B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8101536L (sv) * 1981-03-11 1982-09-12 Astra Laekemedel Ab Bensamid-derivat
SE8205135D0 (sv) * 1982-09-09 1982-09-09 Astra Laekemedel Ab Benzamido-derivatives
CH656126A5 (de) * 1983-08-18 1986-06-13 Ciba Geigy Ag Durch 2-propynyloxygruppen substituierte phthalsaeureanhydride.
SE8400478D0 (sv) * 1984-01-31 1984-01-31 Astra Laekemedel Ab Oxysalicylamido derivatives
US5240957A (en) * 1984-01-31 1993-08-31 Astra Lakemedel Akteibolag Oxysalicylamido derivatives
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2586018B1 (fr) * 1985-08-12 1988-03-25 Ile De France Nouveau benzodioxepanne, son procede de synthese et ses applications en therapeutique
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
US5154913A (en) * 1987-11-19 1992-10-13 Vanderbilt University Radioiodinated benzamines method of their use as radioimaging agents
EP0320630A1 (en) * 1987-11-19 1989-06-21 The Vanderbilt University Enantiometric iodobenzamides
CN1054980A (zh) * 1990-02-19 1991-10-02 杏林制药株式会社 具有旋光活性的8-甲氧基喹诺酮羧酸衍生物,它们的制备方法以及它们的中间体
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
US6517811B2 (en) 1993-05-06 2003-02-11 Research Corporation Technologies, Inc. Compounds for cancer imaging and therapy
WO1994026314A1 (en) * 1993-05-06 1994-11-24 John Christy S Compounds for cancer imaging and therapy
US5993777A (en) * 1993-05-06 1999-11-30 Research Corporation Technologies, Inc. Benzamide compounds for cancer imaging and therapy
US5911970A (en) * 1993-05-06 1999-06-15 Research Corporation Technologies, Inc. Methods for cancer imaging and therapy using benzamine compounds
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN105503666A (zh) * 2015-12-30 2016-04-20 苏州诚和医药化学有限公司 一种便捷合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR6787M (es) * 1967-08-17 1969-03-17
US3891671A (en) * 1968-08-01 1975-06-24 Ile De France N-(2-pyrrolidyl or piperidyl alkyl)-4-hydroxy benzamides
US3959477A (en) * 1968-08-01 1976-05-25 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Methods of protection against emesis in mammals by administration of a heterocyclic benzamide
US3577440A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-amido-pyrrolidines
GB1364231A (en) * 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
FR2097031A1 (en) * 1970-07-29 1972-03-03 Berri Balzac 2-aminoethoxyethyl-6,6-dimethyl nor pinane derivs - local anaesthetics spasmolytics and anticholinergics
GB1392194A (en) * 1971-09-23 1975-04-30 Wyeth John & Brother Ltd Pyrrolidine derivatives
US3966957A (en) * 1972-04-03 1976-06-29 A. H. Robins Company, Incorporated Method for controlling emesis with N-(1-substituted-3-pyrrolidinyl)benzamides and thiobenzamides
US4279822A (en) * 1972-04-03 1981-07-21 A. H. Robins Company, Inc. N-(1-Substituted-3-pyrrolidinyl)benzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
US4048321A (en) * 1973-12-14 1977-09-13 Science Union Et Cie Disubstituted azabicycloalkanes
CH605793A5 (es) * 1974-03-05 1978-10-13 Ile De France
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4172143A (en) * 1974-12-18 1979-10-23 Synthelabo 2-Methoxy-benzamide derivatives
US4158060A (en) * 1974-12-18 1979-06-12 Synthelabo 2-Methoxy-benzamide derivatives
US4039672A (en) * 1975-01-11 1977-08-02 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France N-(1'-allypyrrolidinyl 2'-methyl) 2-methoxy 4,5-azimido benzamide and its pharmaceutically acceptable salts
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
CH614709A5 (es) * 1975-09-25 1979-12-14 Ciba Geigy Ag
JPS5248661A (en) * 1975-10-14 1977-04-18 Synthelabo 22methoxyybenzamide derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
IL61642A0 (en) * 1979-12-20 1981-01-30 Beecham Group Ltd Aniline derivatives,their preparation and pharmalceutical compositions containing them
IL61972A0 (en) * 1980-01-30 1981-02-27 Beecham Group Ltd Azabicyclic compounds,their preparation and pharmaceutical compositions containing them
US4352802A (en) * 1980-06-10 1982-10-05 Beecham Group Limited Bicyclo[3.3.1]nonyl-benzamide
FR2493848B2 (fr) * 1980-11-07 1986-05-16 Delalande Sa Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
IN150618B (es) 1982-11-13
BG48336A3 (en) 1991-01-15
GR64398B (en) 1980-03-21
GB2083459B (en) 1982-12-15
FI69833B (fi) 1985-12-31
NZ196409A (en) 1982-03-09
DK21079A (da) 1979-07-21
AT377254B (de) 1985-02-25
CS241016B2 (en) 1986-03-13
FI790181A (fi) 1979-07-21
PL117195B1 (en) 1981-07-31
SE449862B (sv) 1987-05-25
LU80793A1 (fr) 1979-09-07
FR2440946B2 (es) 1981-07-17
YU10579A (en) 1983-02-28
GB2083459A (en) 1982-03-24
MX6192E (es) 1984-12-13
DK157008C (da) 1990-03-26
AR221428A1 (es) 1981-01-30
AR221355A1 (es) 1981-01-30
IT7947707A0 (it) 1979-01-18
PL212898A1 (es) 1980-03-24
YU41608B (en) 1987-12-31
AU4337479A (en) 1979-07-26
DE2901170C2 (es) 1992-09-17
AU520746B2 (en) 1982-02-25
DK157008B (da) 1989-10-30
CH639369A5 (fr) 1983-11-15
DD141521A5 (de) 1980-05-07
DE2901170A1 (de) 1979-07-26
FR2440946A2 (fr) 1980-06-06
NL7900455A (nl) 1979-07-24
CY1202A (en) 1983-12-31
CH641154A5 (fr) 1984-02-15
YU43809B (en) 1989-12-31
NO790179L (no) 1979-07-23
CA1133477A (en) 1982-10-12
SE8604394D0 (sv) 1986-10-16
BG48335A3 (en) 1991-01-15
SE7900419L (sv) 1979-07-21
JPS54138553A (en) 1979-10-27
OA06153A (fr) 1981-06-30
IL56413A0 (en) 1979-03-12
NO153530C (no) 1986-04-09
ATA301483A (de) 1984-10-15
SE8604394L (sv) 1986-10-16
NZ189381A (en) 1982-03-09
RO80716A (ro) 1982-12-06
CS44479A2 (en) 1985-06-13
JPS6343386B2 (es) 1988-08-30
IE48208B1 (en) 1984-10-31
ES476757A1 (es) 1979-05-16
IE790091L (en) 1979-07-20
US4816471A (en) 1989-03-28
NO153530B (no) 1985-12-30
IT1164821B (it) 1987-04-15
IE48209B1 (en) 1984-10-31
HK12284A (en) 1984-02-24
IL64928A0 (en) 1982-04-30
GB2013662B (en) 1982-10-06
PT69069A (fr) 1979-02-01
SU1158040A3 (ru) 1985-05-23
ES477783A1 (es) 1979-10-16
EG13764A (en) 1982-06-30
GB2013662A (en) 1979-08-15
MX7622E (es) 1990-03-27
FI69833C (fi) 1986-05-26
US4673686A (en) 1987-06-16
CS8083A2 (en) 1985-06-13
RO76554A (ro) 1981-04-30
YU268582A (en) 1987-10-31
MC1231A1 (fr) 1979-10-26
CS241039B2 (en) 1986-03-13
AT377979B (de) 1985-05-28
BE873522A (fr) 1979-07-17
HU177902B (en) 1982-01-28
SE463972B (sv) 1991-02-18
ATA39779A (de) 1983-10-15

Similar Documents

Publication Publication Date Title
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
NO801863L (no) Farmasoeytiske preparater.
IL59524A0 (en) Indole derivatives,their preparation and pharmaceutical compositions containing them
DE3168564D1 (en) Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives
IL56413A (en) Substituted heterocyclic benzamides,their preparation and pharmaceutical compositions containing them
NL188510C (nl) Verstuiver.
NZ186991A (en) 2-(omega,omega-diarylalkyl)-1-azabicyclo(2,2,2)octane derivatives and pharmaceutical compositions
IT7926662A0 (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline.
IL60472A (en) Substituted heterocyclic phenoxyamines,their preparation and pharmaceutical compositions containing them
IL64344A (en) Substituted alkanolamine derivatives,their preparation and pharmaceutical compositions comprising the same
DE2861502D1 (en) New indole derivatives, processes for their preparation, and pharmaceutical compositions containing them.
PH15625A (en) Pyridazopyridazine derivatives,their pharmaceutical compositions and their use
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
NZ180657A (en) 3-aminoalkyl-2-phenyl-bicyclo (2.2.2)-octane or-oct-2-ene derivatives,and pharmaceutical compositions
DE3061160D1 (en) 15-methanesulfonamidoprostaglandin derivatives, pharmaceutical compositions thereof and process therefor
PH13909A (en) 17(-acetylenic-androstenes,the pharmaceutical composition
NZ188097A (en) 3-(substituted amino)-2,1-benzothiazole derivatives and pharmaceutical compositions
DE2861675D1 (en) 2.4-diamino-5-benzylpyrimidines, pharmaceutical compositions containing them and their preparation
ATE6062T1 (de) Pleuromutilin-derivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IT7824037A0 (it) Spiroossazolidinon-derivati steroidei, medicamenti che licontengono e procedimento per laloro preparazione.
ATE8842T1 (de) Ergolin-derivate, ihre herstellung und sie enthaltende therapeutische zusammensetzung.
ES242313Y (es) Biberon antihipo, perfeccionado.
IE791882L (en) Isatin derivatives.
FI834280A (fi) Substituerade dipeptider, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska kompositioner samt foerfarande foer framstaellning av saodana kompositioner.
MX9203580A (es) 1,4-dihidropiridinas y composiciones farmaceuticas que las contienen.